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ABSTRACT 
Objective: The present study focuses on synthesis and characterization of new series of bis-chalcone derivatives from cyclic imides and evaluating 
its antimicrobial activity against a pathogenic microorganism. 
Methods: The substituted cyclic imides 4-methyl phenyl pyrrolidine 2,5 dione 1 and 4-methoxy phenyl pyrrolidine 2,5 dione 2 were synthesized 
from succinic acid and primary aromatic amines. These cyclic imides condensed with substituted benzaldehydes in the presence of acetic acid 
furnished bis-heterocyclic chalcones and characterized by FT-IR, 1H NMR and also microbial activity was determined using the disc diffusion 
method. 
Results: The antimicrobial activity of bis-heterocyclic chalcones was tested against selective pathogens and the zone of inhibition was observed in 
E. coli, C. albicans and A. niger at 100µg/ml concentration.  
Conclusion: The compound (3Z,4Z)-3,4-bis-(2-hydroxybenzylidine)-1-p-tolylpyrrolidine-2,5-dione (3b) with methyl and hydroxyl substituent on 
benzene ring exhibited good antibacterial activity against E. coli and potent antifungal activity against C. albicans and A. niger. 
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Chalcones were synthesized by Claisen Schimidth condensation [1] 
reaction of an aldehyde with acetophenone in the presence of the 
suitable condensing agent, which involved cross aldol condensation. 
The Chalcone is very good synthon for the synthesis of a variety of 
heterocyclic compounds [2] having a therapeutic use. The chalcone 
possesses diverse pharmaceutical application such as Anti-
inflammatory [3], Cytotoxic and Antioxidant [4], Antimicrobial [5], 
Analgesic [6], Anticonvulsant [7] and Anticancer [8]. In recent era 
the chemistry of imides has been extensively studied because of 
their industrial and pharmaceutical uses. The imides derivatives 
have been suggested for treatment of tuberculosis [9]. These are 
used in soap industry as a brightening agent in laundry industry 
[10]. The imide possesses antibacterial activity [11]. In this view, we 
have planned to synthesized bis-chalcone with imide moiety. 
All chemicals used in the present work are of synthetic grade (Loba). 
The melting points were taken in open capillaries and are 
uncorrected. The I. R spectra were recorded on FTIR Shimadzu 
spectrophotometer using KBr disc method. The 1H NMR spectra 
were recorded on Brukar mx-500 MHz in CDCl3 and the chemical 
shift was recorded in δ unit relative to TMS as an internal standard. 
Synthesis of 4-methyl phenyl pyrolidine2, 5 diones 1 
A mixture of succinic acid 0.1 M (11.8 gm) and thionyl chloride 2.2 M 
(15 ml) was refluxed for 30 min and P-toludiene 0.1 M (10.70 gm) 
was dissolved in a suitable amount of benzene. The solution of P-
toludiene added dropwise into the reaction mixture. The reaction 
mixture was then refluxed till complete evolution of HCl gas. Thus, 
crude product was obtained and recrystallized from ethanol. Yield 
80.84 %; M. P 116-118 °C; IR (KBr, cm-1): 1700.31 (C=O), 2931.90 
(C-H of CH3). 
Synthesis of 4-methyl phenyl pyrrolidine 2, 5 dione 2 
A mixture of succinic acid 0.1M (11.8 gm) and thionyl chloride 2.2 M 
(15 ml) was refluxed for 30 min and P-methoxy aniline 0.1 M (12.3 
gm) was dissolved in a suitable amount of benzene. The solution of P-
methoxy aniline added dropwise into reaction mixture. The reaction 
mixture was then refluxed till complete evolution of HCl gas. Thus, 
crude product was obtained recrystallized form ethanol. Yield 61.95 
%; M. P 230 °C; IR (KBr, cm-1):1700.31 (C=O), 2841 (C-H of OCH3). 
General procedure for bis-chalcone synthesis 
Substituted phenyl pyrrolidine 2,5 dione (0.01M) and (0.02M) of 
substituted benzaldehyde in 15 ml acetic acid taken in conical flask. 
The reaction mixture was heated on sand bath for 15-20 min and 
kept it for overnight at room temperature. The solid obtained was 
filtered and recrystallised from ethanol. 
(3Z,4Z)-3,4-bis(2-chlorobenzylidine)-1-p-tolylpyrrolidine-2,5-
dione (3a) 
Yield (69 %); M. P 173-175 °C; IR (KBr, cm-1): 1697.41 (C=O), 1631 
(Ar, C=C), 716.58 (C-Cl); 1H NMR (CDCl3):δ: 8.22-6.43 (m,6H, Ar-H 
and =CH), 2.38 (s,3H,CH3). Anal. Calcd for C25H17Cl2NO2: C, 69.14; H, 
3.95; N, 2.23%; Found: C, 69.25; H, 3.98; N, 2.31%. 
(3Z,4Z)-3,4-bis(2-hydroxybenzylidine)-1-p-tolylpyrrolidine-
2,5-dione (3b) 
Yield (85%); M. P 166-168 °C; IR (KBr, cm-1): 1707.06 (C=O), 3462.34 
(-OH) 2932.78 (CH of CH3); 1H NMR (CDCl3): δ: 2.40 (s, 3H, CH3), 5.1 (s, 
OH), 7.31-7.17(m,6H, Ar-H and =CH). Anal. Calcd for C25H19NO4: C, 
75.55; H, 4.82; N, 3.52%. Found: C, 75.63; H, 4.88; N, 3.59%. 
(3Z,4Z)-3,4-bis(3-nitrobenzylidine)-1-p-tolylpyrrolidine-2,5-
dione (3c) 
Yield (80 %); M. P 198-200 °C; IR (KBr, cm-1): 1707 (C=O), 1291.39 
(C-NO2), 804 (Ar, C-H); 1H NMR (CDCl3):δ: 8.47-6.67 (m,6H, Ar-H and 
=CH), 2.30 (s, 3H, CH3); Anal. Calcd for C25H17N3O6: C, 65.93; H, 3.76; 
N, 9.23%; Found: C, 65.97; H, 3.82; N, 9.31%. 
(3Z,4Z)-3,4-bis(3-nitrobenzylidine)-1-(4-methoxyphenyl) 
pyrrolidine-2,5-dione(4a) 
Yield (76 %); M. P 158-160 °C; IR (KBr, cm-1): 1707 (C=O), 
1534.42(C-NO2), 2839.78 (C-H, O-CH3);1H NMR (CDCl3): δ: 7.28-7.0 
(m,7H, Ar-H and =CH), 3.85 (s, 3H, OCH3); Anal. Calcd for C25H17N3O7: 
C, 63.69; H, 3.63; N, 8.91%; Found: C, 63.8; H, 3.76; N, 8.96%. 
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Yield (69 %); M. P 164-166 °C, IR (KBr,cm-1):1697.41 (C=O cyclic 
imide), 716.5 (C-Cl), 2840.28 (C-H, O-CH3),1631.83(Ar, C=C);1H NMR 
(CDCl3):δ: 7.28-6.99 (m,7H, Ar-H and =CH), 3.84 (s, 3H, OCH3); Anal. 
Calcd for C25H17Cl2NO3: C, 66.68; H, 3.81; Cl, 15.75; N, 3.11%; Found: 
C, 66.78; H, 3.92; Cl, 15.87; N, 3.31%. 
(3Z, 4Z)-3, 4-bis (4-methylbenzylidine)-1-(4-methoxyphenyl) 
pyrrolidine-2,5-dione (4c) 
Yield (89 %); M. P 154-160 °C; IR (KBr, cm-1): 1705.13 (C=O cyclic 
imide), 2840.78 (C-H, O-CH3), 2937.68 (C-H of CH3), 1608.69(Ar, 
C=C); 1H NMR (CDCl3): δ: 7.28-7.0 (m,7H, Ar-H and =CH), 3.85(s, 3H, 
OCH3), 2.44 (s,3H,CH3); Anal. Calcd for C27H23NO3: C, 79.20; H, 5.66; 
N, 3.42%; Found: C, 79.51; H, 5.73; N, 3.59%. 
(3Z,4Z)-3,4-bis(2-hydroxybenzylidine)-1-(4-methoxyphenyl) 
pyrrolidine-2,5-dione(4d) 
Yield (69 %); M. P 150-152 °C; IR (KBr, cm-1): 1708.99 (C=O cyclic 
imide), 2841.24 (C-H, O-CH3), 3462.34 (-OH), 1608.69 (Ar, C=C); 1H 
NMR (CDCl3):δ: 7.28-6.99 (m,7H, Ar-H and =CH), 5.4 δ (s, OH) 3.85 
(s, 3H, OCH3); Anal Calcd for C25H19NO5: C,72.62; H,4.63; N,3.99%; 
Found: C,72.81; H,4.77; N,3.46%. 
(3Z,4Z)-3,4-bis(4-mthoxybenzylidine)-1-(4-methoxyphenyl) 
pyrrolidine-2, 5-dione (4e) 
Yield (71 %); M. P 162-164 °C; IR (KBr, cm-1): 1705.13 (C=O cyclic 
imide), 1178.25 (C-O, OCH3), 2920.32 (C-H, O-CH3), 1512.24 (Ar, 
C=C); 1H NMR (CDCl3):δ: 7.28-6.99 (m,7H, Ar-H and =CH), 3.85 (s, 
3H, OCH3); Anal. Calcd for C27H23NO5: C, 73.46; H, 5.25; N, 3.73%; 






































The cyclic imides 1 and 2 are required for synthesis of bis-
heterocyclic chalcones were prepared by reaction of the succinic 
acid with thionly chloride. To provide succinyl chloride in situ this 
was condensed with P-toludiene and P-methoxy aniline in the 
presence of benzene (Scheme 1). The IR spectra of compound 1 
shows frequency at 1700.31 Cm-1 is due to the presence of cyclic 
five-membered imide group CO-N-CO and 2931.90 Cm-1 is 
corresponded to C-H stretching frequency of–CH3 group. The 1H 
NMR Spectrum in CDCl3 shows a characteristic peak of four 
succinamide protons shows peak around 2.8 δ and methyl proton at 





















c = - 4-CH3
e = - 4-OCH3,
 
 
The IR spectra of compound 2 shows frequency at 1700.31 Cm-1 due 
to the presence of cyclic five-membered imide group CO-N-CO. The 
1H NMR Spectrum in CDCl3 shows a characteristic peak of methoxy 
proton as a singlet at 3.8 δ. The bis-heterocyclic compounds 3a-c 
were synthesized by reaction of compound 1 with O-chloro- 
benzaldehyde, O-hydroxy benzaldehyde, M-nitrobenzaldehyde in 
the presence of acetic acid (Scheme 2). The imide 2 Condensed with 
M-nitrobenzaldehyde, O-chloro- benzaldehyde, P-methyl 
benzaldehyde, O-hydroxy benzaldehyde and P-methoxy 
benzaldehyde in the presence of acetic acid furnished into bis-
heterocyclic chalcone 4a-c (Scheme 3).  
All synthesized compounds 3a-c and 4a-e were evaluated in–vitro 
against bacterial strains Gram-positive bacteria Staphylococcus 
aureus and Bacillus subtilis, Gram-negative bacteria Escherichia coli 
and pseudomonas aeuroginosa [12]. The solvent DMSO was used to 
prepared aliquots of 3a-c and 4a-e compounds and the final 
concentration 100µg/ml per disc was adjusted. The disc diffusion 
method was used to evaluate antimicrobial activity. For this, 
nutrient agar was employed as culture media. The results were 
obtained in the form of a zone of inhibition and were noted after the 
period of incubation (at 37 °C for 24-28 h).  
 
Table 1: It shows microbial evaluation (zone if inhibition in mm) of compound 3a-c and 4a-e 
Compound E. coli P. aeruginosa  S. aureus B. subtilis  C. albicans  A. niger 
3a NA NA NA NA NA NA 
3b 15.23±1.11 NA NA NA 12.35±1.01 15.28±1.08 
3c NA NA NA NA NA NA 
4a NA NA NA NA NA NA 
4b NA NA NA NA NA NA 
4c NA NA NA NA NA NA 
4d NA NA NA NA NA NA 
4e NA NA NA NA NA NA 
Ciprofloxacin  19.59±1.30  9.33±1.17  18.27±1.17  21.28±1.09  - - 
Amphotericine-B - - - - 11.25±1.15  11.63±1.05 
Note: NA means No activity at 100µg/ml,-means Not applicable, n=3 
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Fig. 1: Agar plate exhibiting the zone of inhibition by compound (3Z,4Z)-3,4-bis(2-hydroxybenzylidine)-1-p-tolylpyrrolidine-2,5-dione 
(3b) against fungi A. nigar at 100µg/ml 
 
The zone of inhibitions was measured in mm and similarly, 
compounds 3a-c and 4a-e were evaluated in–vitro against for 
antifungal activity against Fungi (Yeast) Candida albicans, Fungi 
(Mould) Aspergillus niger at the concentration 100µg/ml per disc by 
disc diffusion method using DMSO as a solvent. The experiment was 
in triplicate, average and standard deviation were calculated.  
The antimicrobial results were compared with antibiotic Ciprofloxacin 
and Amphotericine-B as standard and summarized in table 1. Literature 
survey suggested that chalcone derivative having hydroxyl substituent 
did not shows antibacterial activities at about 1000 µg/ml concentration 
[13] but in present work the synthesized bis-heterocyclic chalcone 3b 
possessing hydroxyl substituent display promising antibacterial activity 
against Escherichia coli at only 100 µg/ml concentration. 
CONCLUSION 
The study concluded that among all synthesized compounds the 
compound (3Z,4Z)-3,4-bis(2-hydroxybenzylidine)-1-p-tolylpyrrolidine- 
2,5-dione (3b) exhibited good antibacterial activity against E. coli, 
and potent antifungal activity against Candida albicans and 
Aspergillus niger. The remaining compound does not exhibited 
microbial activities 100µg/ml concentration. 
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